FIELD: medicine.
SUBSTANCE: method involves applying high-performance liquid chromatography in supernatant produced by precipitating blood plasma proteins with acetonitrile. To do it, Pronto SIL-120-5-C18AQ chromatographic column of 2x75 mm with particle size of 5 mcm is used. 0.1 M sodium dihydrophosphate solution and acetonitrile mixture is used as eluent with acetonitrile concentration gradient being from 0 to 50% and eluent flow supply rate being equal to 90 mcl/min, eluting volume 1500 mcl, chromatographic column temperature 35°C. Detection is carried out at wavelength of 210 nm.
EFFECT: high accuracy in determining histamine concentration.
2 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF QUANTITATION 2,2,6,6-TETRAMETHYL-N-{1-[5-(4-METHYL-3-CHLOROANILINE)-1,2,4-THIADIAZOLE-3-YL]PROPAN-2-YL}PIPERIDIN-4-AMINE DIHYDROCHLORIDE IN BIOLOGICAL MATRICES | 2016 |
|
RU2636231C1 |
METHOD FOR EXPRESS DIAGNOSTICS OF HIDDEN INFLAMMATORY PROCESSES OF BREAST AND REPRODUCTIVE ORGANS OF COWS | 2016 |
|
RU2629273C1 |
METHOD OF QUANTITATIVE DETERMINATION OF 8-(TRIFLUOROMETHYL)BENZO[f][1,2,3,4,5]PENTATHIEPIN-6-AMINE HYDROCHLORIDE IN BIOLOGICAL MEDIA | 2018 |
|
RU2676487C1 |
METHOD FOR DETERMINING AMIODARONE AND ITS MAIN METABOLITE DESETHYLAMIODARONE IN HUMAN BLOOD SERUM | 2020 |
|
RU2749566C1 |
METHOD FOR DETERMINING LOSARTAN, ITS MAIN METABOLITE LOSARTAN CARBOXYLIC ACID AND GLIBENCLAMIDE IN HUMAN BLOOD SERUM AND URINE | 2020 |
|
RU2749567C1 |
METHOD FOR DETERMINATION OF CIPROFLOXACIN BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY | 2020 |
|
RU2751338C1 |
METHOD FOR MONITORING THE CONTENT OF ANTI-TUBERCULOSIS PREPARATIONS OF THE MAIN LINE AND THEIR TOXIC METABOLITES IN BLOOD PLASMA | 2018 |
|
RU2702998C1 |
METHOD FOR DETERMINING CONTENT OF FUMARIC AND MALEIC ACIDS IN BLOOD PLASMA BY METHOD OF HIGHLY EFFECTIVE LIQUID CHROMATOGRAPHY | 2018 |
|
RU2677341C1 |
METHOD FOR DETERMINATION OF AMINOGLYCOSIDE ANTIBIOTICS BY REVERSE-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY | 2022 |
|
RU2786839C1 |
METHOD FOR QUANTITATIVE DETERMINATION OF N-[3-(4-NITROPHENYLAMINO)-INDOLE-2-YLMETHYLENE]AMINOGUANIDINE METHANESULPHONATE IN BLOOD PLASMA | 2018 |
|
RU2699550C1 |
Authors
Dates
2007-07-10—Published
2005-05-11—Filed